- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in Anti-IgE Therapy
Authors
Keywords
-
Journal
Biomed Research International
Volume 2015, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2015-05-06
DOI
10.1155/2015/317465
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria
- (2015) Tse Wen Chang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab Induced Remission of Idiopathic Anaphylaxis in a Patient Suffering from Indolent Systemic Mastocytosis
- (2014) L Kibsgaard et al. ACTA DERMATO-VENEREOLOGICA
- An Overview of the Effects of anti-IgE Therapies
- (2014) Arzu Didem Yalcin MEDICAL SCIENCE MONITOR
- Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
- (2014) Sylvia Lehmann et al. Therapeutic Advances in Respiratory Disease
- Clinical Management of Asthma
- (2013) ALLERGY
- Evaluation of D-dimer serum levels among patients with chronic urticaria, psoriasis and urticarial vasculitis
- (2013) Paulo Ricardo Criado et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy
- (2013) Nicola A. Hanania et al. ANNALS OF INTERNAL MEDICINE
- Clinical Course and Side Effects of Anti-IgE Monoclonal Antibody in Patients with Severe Persistent Asthma
- (2013) Arzu Yalcin et al. Clinical Laboratory
- Anti-IgE Monoclonal Antibody (Omalizumab) is effective in Treating Bullous Pemphigoid and Its Effects on Soluble CD200
- (2013) Arzu Yalcin et al. Clinical Laboratory
- D-dimer levels decreased in severe allergic asthma and chronic urticaria patients with the omalizumab treatment
- (2013) Arzu Didem Yalcin et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Anti-IgE – emerging opportunities for Omalizumab
- (2013) K Suresh Babu et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels
- (2013) Arzu Didem Yalcin et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1βand sCD200 in cases of Samter's syndrome: 36 months follow-up
- (2013) Arzu Didem Yalcin et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Immunologic Effects of Omalizumab in Children with Severe Refractory Atopic Dermatitis: A Randomized, Placebo-Controlled Clinical Trial
- (2013) Shuba Rajashri Iyengar et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
- (2013) Allen Kaplan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: A retrospective clinical analysis
- (2013) Martin Metz et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Severe and uncontrolled adult asthma is associated with vitamin D insufficiency and deficiency
- (2013) Stephanie Korn et al. RESPIRATORY RESEARCH
- Asthma and coagulation
- (2012) J. D. de Boer et al. BLOOD
- Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics
- (2012) Britta Haenisch et al. IMMUNOLOGY
- Systemic levels of ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis
- (2012) Arzu Didem Yalcin et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Serum 25-dihydroxyvitamin D levels correlate with CD4+Foxp3+ T-cell numbers in moderate/severe asthma
- (2012) Emma S. Chambers et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab and the risk of malignancy: Results from a pooled analysis
- (2012) William Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma
- (2012) Philippe Gevaert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Longitudinal Changes in Asthma Control with Omalizumab: 2-Year Interim Data from the EXCELS Study
- (2012) Mark D. Eisner et al. JOURNAL OF ASTHMA
- Omalizumab Therapy in Severe Asthma: Experience from the Spanish Registry—Some New Approaches
- (2012) María Del Carmen Vennera et al. JOURNAL OF ASTHMA
- Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation
- (2012) Olivia S. Anderson et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- IL-8, IL-10, TGF-β, and GCSF Levels Were Increased in Severe Persistent Allergic Asthma Patients with the Anti-IgE Treatment
- (2012) Arzu D. Yalcin et al. MEDIATORS OF INFLAMMATION
- Neurotensin and CRH Interactions Augment Human Mast Cell Activation
- (2012) Konstantinos–Dionysios Alysandratos et al. PLoS One
- Eosinophilic gastroenteritis: an update
- (2012) Alfredo J Lucendo et al. Expert Review of Gastroenterology & Hepatology
- Systemic Mastocytosis
- (2011) Didem Ozdemir et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Eosinophilic colitis: an update on pathophysiology and treatment
- (2011) A. A. Alfadda et al. BRITISH MEDICAL BULLETIN
- Omalizumab Treatment of Systemic Mast Cell Activation Disease: Experiences from Four Cases
- (2011) Gerhard J. Molderings et al. INTERNAL MEDICINE
- 1,25-dihydroxyvitamin D3 influences cellular homocysteine levels in murine preosteoblastic MC3T3-E1 cells by direct regulation of cystathionine β-synthase
- (2011) Carsten Kriebitzsch et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Long-term omalizumab treatment in severe allergic asthma: The South-Eastern Mediterranean “real-life” experience
- (2011) Eleni G. Tzortzaki et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Baseline characteristics of patients enrolled in EXCELS: a cohort study
- (2010) Aidan A. Long et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Current approaches to the diagnosis and treatment of systemic mastocytosis
- (2010) Sonia N. Bains et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Mast Cells and Mastocytosis
- (2010) Johan D. Söderholm DIGESTIVE DISEASES
- Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma
- (2010) Marc Massanari et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Italian real-life experience of omalizumab
- (2010) M. Cazzola et al. RESPIRATORY MEDICINE
- Eosinophilic colitis: epidemiology, clinical features, and current management
- (2010) Abdulrahman A. Alfadda et al. Therapeutic Advances in Gastroenterology
- Effects of omalizumab on markers of inflammation in patients with allergic asthma
- (2009) S. Holgate et al. ALLERGY
- EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria
- (2009) T. Zuberbier et al. ALLERGY
- Mastocytosis
- (2009) Hans-Peter Horny AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications
- (2009) S. Danese et al. BLOOD
- Pathogenesis of Hyper IgE Syndrome
- (2009) Jennifer Heimall et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge
- (2009) John A. Eckman et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany
- (2009) S. Korn et al. RESPIRATORY MEDICINE
- “Real-life” effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study
- (2009) G. Brusselle et al. RESPIRATORY MEDICINE
- ALLERGY Net: High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis
- (2008) K. Kontou-Fili ALLERGY
- Mast cells and mastocytosis
- (2008) D. D. Metcalfe BLOOD
- Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases
- (2008) K. D. Stone et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma
- (2008) M. V. Kopp et al. CLINICAL AND EXPERIMENTAL ALLERGY
- The Hyper-IgE Syndromes
- (2008) Alexandra F. Freeman et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- New targets for drug development in asthma
- (2008) Ian M Adcock et al. LANCET
- Effectiveness of omalizumab (Xolair®) in the first patients treated in real-life practice in France
- (2007) Mathieu Molimard et al. RESPIRATORY MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now